We are live on ! Find out more
MCM

McRae Capital Management Portfolio holdings

AUM $508M
1-Year Est. Return 14.21%
This Fund
S&P 500
This Quarter Est. Return
+8.18%
1 Year Est. Return
+14.21%
3 Year Est. Return
+59.23%
5 Year Est. Return
+71.2%
10 Year Est. Return
+359.88%
AUM
$271M
AUM Growth
+$14.9M
Cap. Flow
-$3.08M
Cap. Flow %
-1.13%
Top 10 Hldgs %
42.44%
Holding
101
New
10
Increased
26
Reduced
33
Closed
3

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$6.41M
2
CRNC icon
Cerence
CRNC
+$894K
3
KEYS icon
Keysight
KEYS
+$734K
4
OMC icon
Omnicom Group
OMC
+$427K
5
KMI icon
Kinder Morgan
KMI
+$423K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$10.1M
2
TPR icon
Tapestry
TPR
+$3.33M
3
XOM icon
ExxonMobil
XOM
+$291K
4
MMM icon
3M
MMM
+$230K
5
ADP icon
Automatic Data Processing
ADP
+$199K

Sector Composition

Rank Sector Weight
1 Technology 28.26%
2 Healthcare 17.57%
3 Financials 17.49%
4 Consumer Discretionary 15.03%
5 Communication Services 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELG
101
DELISTED
Celgene Corp
CELG
– –
-101,867
Closed -$10.1M
1 2 3 4
5

Similar funds

MCM
Maltese Capital Management New York $508M AUM 21.31% 1-Year Est. Return
MC
Machina Capital Paris, France $508M AUM 9.91% 1-Year Est. Return
OA
Oasis Advisors Forest City, Iowa $509M AUM
MCA
Magnolia Capital Advisors Jackson, Mississippi $509M AUM 18.99% 1-Year Est. Return
WMG
WESCAP Management Group Glendale, California $508M AUM 18.98% 1-Year Est. Return
PWMG
Prestige Wealth Management Group Flemington, New Jersey $509M AUM 15.69% 1-Year Est. Return
RFG
REAP Financial Group Austin, Texas $507M AUM 18.73% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

McRae Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, McRae Capital Management held 101 positions worth $271M, up 5.8% from $257M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

McRae Capital Management's Q4 2019 filing shows 10 new, 26 increased, 33 reduced and 3 closed positions. Its largest new stake was Cerence: 54,517 shares worth $1.23M. The largest sale was Celgene Corp, an estimated $10.1M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

  • McRae Capital Management's largest Q4 2019 buy was Cerence: 54,517 shares worth $1.23M.
  • McRae Capital Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $6.41M increase.
  • McRae Capital Management's biggest Q4 2019 reduction was ExxonMobil, cutting an estimated $291K.
  • McRae Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $10.1M.
  • McRae Capital Management's ten largest holdings make up 42% of its $271M portfolio in Q4 2019.
  • McRae Capital Management opened 10 new positions and closed 3 in Q4 2019.
  • McRae Capital Management's portfolio value rose 5.8% quarter-over-quarter to $271M.

Based on McRae Capital Management's 13F filing for Q4 2019, filed 17 Jan 2020.